Synthesis, spectral characterization and antimicrobial activity of thiourea/urea derivatives of amlodipine

Similar documents
Synthesis and Antimicrobial Evaluation of some 2-Azetidinone derivatives

Tetramethyl guanidine (TMG) catalyzed synthesis of novel α-amino phosphonates by one-pot reaction

The First Au-Nanoparticles Catalyzed Green Synthesis of Propargylamines Via Three-Component Coupling Reaction of Aldehyde, Alkyne And Amine

Supporting Information. Copper-catalyzed cascade synthesis of benzimidazoquinazoline derivatives under mild condition

International Journal of Pharma and Bio Sciences V1(2)2010 SY THESES A D BIOLOGICAL ACTIVITY OF SOME 3, 5-DRIARYL-4H-1, 2, 4-TRIAZOLE DERIVATIVES

Paresh S. More*, Santosh G. Singh. Department of Chemistry, KET S V.G Vaze College, Mulund(E), Mumbai , Maharashtra, India

Copper(II) Ionic Liquid Catalyzed Cyclization-Aromatization of. Hydrazones with Dimethyl Acetylenedicarboxylate: A Green Synthesis

Manganese powder promoted highly efficient and selective synthesis of fullerene mono- and biscycloadducts at room temperature

Allenylphosphine oxides as simple scaffolds for. phosphinoylindoles and phosphinoylisocoumarins

Ruthenium-Catalyzed C H Oxygenation on Aryl Weinreb Amides

Supporting Materials. Experimental Section. internal standard TMS (0 ppm). The peak patterns are indicated as follows: s, singlet; d,

Zinc Chloride Promoted Formal Oxidative Coupling of Aromatic Aldehydes and Isocyanides to α- Ketoamides

Electronic Supplementary Information

Stereoselective Aza-Darzens Reactions of Tert- Butanesulfinimines: Convenient Access to Chiral Aziridines

Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page:

Supporting Information. Efficient copper-catalyzed Michael addition of acrylic derivatives with primary alcohols in the presence of base

Divergent Construction of Pyrazoles via Michael Addition of N-Aryl Hydrazones to 1,2-Diaza-1,3-dienes

A Novel Synthesis of Arylpyrrolo[1,2-a]pyrazinone Derivatives

Electronic Supplementary Information (ESI)

National Defense Academy, Hashirimizu, Yokosuka, , Japan

Improved Carbonylation of Heterocyclic Chlorides and Challenging Aryl Bromides

Supporting Information. Radical fluorination powered expedient synthesis of 3 fluorobicyclo[1.1.1]pentan 1 amine

Synthesis and antimicrobial activity of novel (3a,S)-1-(aminoacid ester)-3a,4-dihydro-3h-1λ 5 -[1,3,2] oxazaphospholo[3,4-a] indol-1-oxides

Synthetic chemistry-led creation of a difluorinated biaryl ether non-nucleoside reverse transcriptase inhibitor

SUPPORTING INFORMATION. Transition metal-promoted synthesis of 2-aryl/heteroaryl-thioquinazoline: C-S

Supporting Information

Enantioselective synthesis of anti- and syn-β-hydroxy-α-phenyl carboxylates via boron-mediated asymmetric aldol reaction

Synthesis and antitumor evaluation in vitro of 5-bromo-N-phenyl substituted isatin derivatives

TWO NEW ELLAGIC ACID GLYCOSIDES FROM LEAVES OF DIPLOPANAX STACHYANTHUS

Supporting Information for. Use of the Curtius Rearrangement of Acryloyl Azides in the Synthesis of. 3,5-Disubstituted Pyridines: Mechanistic Studies

SUPPORTING INFORMATION. Studies on antimicrobial evaluation of some 1-((1-(1H-benzo[d]imidazol-2-

International Journal Of Scientific Research And Education Volume 3 Issue 6 Pages June-2015 ISSN (e): Website:

Vol-3, Issue-3, July-2012 ISSN: Panda et al

Synthesis of Some 4-Thiazolidinone Derivatives as Antitubercular Agents

Supporting Information. as the nitro source

Supporting Information

2 - chloro phenothiazine was prepared by the method of knoevenagal (loc. cit); (1914). 2-Chloro-10-chloroacetyl phenothiazine (1): To a solution of

Isolation & Antimicrobial Screening of Ten Long Chain Aliphatic Compounds from Psidium guajava (Leaves)

Solid Phase Peptide Synthesis (SPPS) and Solid Phase. Fragment Coupling (SPFC) Mediated by Isonitriles

Supporting Information

SYNTHESIS, CHARACTERIZATION AND BIOLOGICAL ACTIVITIES OF SOME 1-(NICOTINYLAMINO) -2 SUBSTITUTED AZETIDINE-4 -ONES AS POTENTIAL ANTIBACTERIAL AGENTS

ISSN: A one-pot multi component synthesis of triazolopyrimidines

Rameshwar Prasad Pandit and Yong Rok Lee * School of Chemical Engineering, Yeungnam University, Gyeongsan , Korea

Supporting Information

p-toluenesulfonic Acid-Mediated 1,3-Dipolar Cycloaddition of

Synthesis and biological activities of some 3,5-disubstituted-Δ²-pyrazoline derivatives

Supporting information for

Catalytic decarboxylative alkylation of β-keto acids with sulfonamides via the cleavage of carbon nitrogen and carbon carbon bonds

1,5-Electrocyclization of conjugated azomethine ylides derived from 3-formyl chromene and N-alkyl amino acids/esters

CHAPTER - 3. SYNTHESIS OF INDENO[1,2-d]PYRIMIDINE-2-THIONES AND EXPERIMENTAL. plates and spots were located by iodine vapours. Infra red spectra were

Supporting Information Synthesis of 2-Aminobenzonitriles through Nitrosation Reaction and Sequential Iron(III)-Catalyzed C C Bond Cleavage of 2-Arylin

Development of a near-infrared fluorescent probe for monitoring hydrazine in serum and living cells

ANTIMICROBIAL SCREENING OF N-[(2-SUBSTITUTED PHENYL)-4-OXO-1,3-THIAZOLIDINE 3- YL]ISONICOTINAMIDES

Eur. J. Org. Chem WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim, 2007 ISSN X SUPPORTING INFORMATION

Supplemental Information. Reactivity of Monovinyl (Meth)Acrylates Containing Cyclic Carbonates

Nitro-Grela-type complexes containing iodides. robust and selective catalysts for olefin metathesis

Supporting information

SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF SOME NEW 2,4,6-TRISUBSTITUTED PYRIMIDINES

SYNTHESIS, SPECTROSCOPIC AND FUNGICIDAL STUDIES OF COPPER SOAPS DERIVED FROM MUSTARD AND SOYABEAN OILS AND THEIR UREA COMPLEXES

Schwartz s reagent-mediated regiospecific synthesis of 2,3-disubstituted indoles from isatins

SYNTHESIS OF 6-CHLOROFLAVONE FROM 4-CHLOROPHENOL AND THEIR BIOCIDAL ACTIVITY

Supporting Information

Design, synthesis and evaluation of ph-dependent hydrolysable emetine analogs as treatment for prostate cancer.

Synthesis and Antimicrobial Activity of Novel Pyrazole-5-one Containing 1, 3, 4-oxadiazole Sulfonyl Phosphonates

Scholars Research Library

Use of degradable cationic surfactants with cleavable linkages for enhancing the. chemiluminescence of acridinium ester labels. Supplementary Material

Supporting Information

L-Carnosine-Derived Fmoc-Tripeptides Forming ph- Sensitive and Proteolytically Stable Supramolecular

Synthesis and Blastocyst Implantation Inhibition Potential of Lupeol Derivatives in Female Mice

Electronic Supplementary Information (ESI)

Supporting Information

Synthesis of 7-aryl/heteraryl-1,3-diphenyl- 1,2,4-benzotriazinyls via palladium catalyzed Stille and Suzuki-Miyaura reactions

ISSN: X Available Online through Research Article

SYNTHESIS, CHARACTERIZATION AND ANTIMICROBIAL STUDY OF NEW S-MALTOSYLATED 1,2,4-THIADIAZOLINES

An efficient synthesis, characterization and anti-bacterial activity of pyrimidine bearing 1,3,4-thiadiazole derivatives

An Unusual Glycosylation Product from a Partially Protected Fucosyl Donor. under Silver Triflate activation conditions. Supporting information

FLAVANONE AND FLAVONE GLYCOSIDE FROM TAXUS BACCATA

Supporting Information

Development and validation of liquid chromatographic method for trazodone hydrochloride

Supporting Information. for. Access to pyrrolo-pyridines by gold-catalyzed. hydroarylation of pyrroles tethered to terminal alkynes

β-sitosterol-3-o-β-d-xylopyranosyl (1 4)-O-β-D- GLUCOPYRANOSIDE FROM THE SEEDS OF ZANTHOXYLUM HEMILTONIANUM WALL

Acyl Radical Reactions in Fullerene Chemistry: Direct Acylation of. [60]Fullerene through an Efficient Decatungstate-Photomediated Approach.

Syntheses and antitumor activity of some 1,2,4 triazine derivatives

molecules ISSN

Continuous flow retro-diels Alder reaction: an. efficient method for the preparation of pyrimidinone

SYNTHESIS OF 2-AMINOPYRIMIDINE DERIVATIVES AS ANTIMICROBIAL AGENTS

Supporting Information. for. Pd-catalyzed decarboxylative Heck vinylation of. 2-nitro-benzoates in the presence of CuF 2

Thermal shift binding experiments were carried out using Thermofluor 384 ELS system. Protein

Copyright Wiley-VCH Verlag GmbH, D Weinheim, Angew. Chem

molecules ISSN

SUPPLEMENTARY MATERIAL

Regioective Halogenation of 2-Substituted-1,2,3-Triazole via sp 2 C-H Activation

Pharmacophore 2015, Vol. 6 (4), USA CODEN: PHARM7 ISSN Pharmacophore. (An International Research Journal)

Preparation of Stable Aziridinium Ions and Their Ring Openings

Masatoshi Shibuya,Takahisa Sato, Masaki Tomizawa, and Yoshiharu Iwabuchi* Department of Organic Chemistry, Graduate School of Pharmaceutical Sciences,

ph Switchable and Fluorescent Ratiometric Squarylium Indocyanine Dyes as Extremely Alkaline Sensors

Electronic Supplementary Information

SUPPORTING INFORMATION

Supporting Information

A Hierarchy of Aryloxide Deprotection by Boron Tribromide. Supporting Information

Transcription:

Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 20, 5 (1):1-204 (http://scholarsresearchlibrary.com/archive.html) ISS 05-501 USA CDE: DPLEB4 Synthesis, spectral characterization and antimicrobial activity of thiourea/urea derivatives of amlodipine P. Vedavathi a, K. Chandra Sekhar a and C. aga Raju a, * Department of Chemistry, Sri Venkateswara University, Tirupati, A.P., India ABSTRACT Amlodipine is one of the calcium channel blockers havingdihydropyridine group, used as an antihypertensive drug.a series of novel ureaandthioureaderivativesofamlodipine(1) were prepared by reacting (1) with various substituted isocyanates/isothiocyanates in the presence of triethylamine in TF at 50 C. Their structures were established by IR, 1, CMR, Mass spectral data and C,, elemental analysis. Their antimicrobial activity was evaluated and the title compounds exhibited moderate antimicrobial activity. Key words: Amlodipine, Urea and thiourea derivatives, Antimicrobial activity. ITRDUCTI Amlodipine (3-ethyl-5-methyl(±) 2-((2-aminoethoxy) methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine- 3,5-dicarboxylate), commercially available as orvasc is a long acting calcium channel blocker used as an antihypertensive drug 1 and the mechanism involved in it is a dihydropyridine calcium antagonist that inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle [2]. The contractile process of cardiac muscle and vascular smooth muscle are dependent upon the movement of extracellular calcium ion into these cells through specific ion channels [3]. It inhibits calcium ion influx across cell membrane selectively, with a greater effect on vascular smooth muscle than on cardiac muscle to cause a reduction in peripheral vascular resistance and reduction in blood pressure [4]. Urea and thiourea derivatives possess potent anticancer properties [5-]. Thiourea derivatives display a wide range of biological activity including antibacterial, anti-fungal, antitubercular, antihelmintic, rodenticidal, insecticidal, herbicidal and plant growth regulatory properties [-]. The importance of such work lies in the possibility of the thiourea derivatives might be more efficacious as antimicrobial and anticancer agents. owever, a thorough investigation relating tothe structure and the activity of the thiourea derivatives as well as their stability under biological conditions is required. These detailed investigations could be helpful in designing more potent antimicrobial agents for the therapeutic use. Since varying substituent on abasic structural frame work is a common method for drug design in medicinal chemistry and a useful medical value of substituted thiourea derivatives. Based on the importance of amlodipine, it is designed and synthesized a series of novel urea and thiourea derivatives of amlodipine in high yield. 1

C. aga Raju et al Der Pharmacia Lettre, 20, 5 (1):1-204 Me Et 3 TF, 50 C 2hr Me Et 3. PhS 3 (1) 2 (2) PhS 3 2 Me (2) R CX TF, Et 3 40-50 ο C 2 3(a-d), X= 3(e-k), X=S Me 4(a-d), X= 4(e-k), X=S C X R C C C C 2 C C C 2 CS C 4a 4b 4c F 4d 4e CS C CS CS CS 2 2 2 4f 4g 4h 4i 4j CS 4k MATERIALS AD METDS Chemistry: All the chemicals were purchased from Sigma-Aldrich and used without further purification. TLC was performed on pre-coated plates with silica gel 60F254 (Merck). Column chromatography was performed on silica gel (0.040-.063 mm, Macherey, agel). Melting points were recorded on Buchi R-535 (Flawil, Switzerland) apparatus and are uncorrected. IR Spectra were recorded on JASC Japan FT/IR -5300. 1, and C MR spectra were recorded on Bruker A VIII 500 Mz MR spectrometer operating at 500 Mz for 1 and 5 Mz for C.MR data were recorded in DMS-d 6 and were referenced to TMS ( 1 and C). Mass spectra were recorded on 200

C. aga Raju et al Der Pharmacia Lettre, 20, 5 (1):1-204 LC-MS 20A Shimadzu(Japan), spectrometer at University of yderabad, yderabad. Elementary analyses were performed using EA Thermo Finnigan(France), instrument at University of yderabad, yderabad, India. SYTESIS: General synthetic procedure of synthesis of 4a-k. A solution of Amlodipine benzene sulfonic acid (1.5 g, 0.003 mole) in 20 ml of dry TF was treated with triethyl amine (0. ml, 0.003 mole) in 25 ml of TF at o C. After stirring for 2h at 50 o C, formation of 2(free base) was ascertained by TLC analysis run in a 3: mixture of ethylacetate and hexane and the average R f value observed was 0.5. Et 3.PhS 3 was removed by filtration. The filtrate containing 2was used for the next reaction step without further purification. To a stirred solution of Amlodipine (2) in 20 ml dry TF, a solution of 4-chlorophenylisocyanate (3a) (0.001mole) in ml of dry TF was added dropwise at room temperature in the presence of triethylamine (0.001 mole). After the completion of the addition, the temperature of the reaction was raised to 40-50 o C and the reaction mixture was stirred for 3 h. After the completion of the reaction, as indicated by TLC conducted in 3: mixture of ethyl acetate and hexane, an average R f value of 0.60 was observed. It was purified by column chromatography on silica gel (0-200 mesh) eluting with ethyl acetate: hexane, 1:) to afford the pure compound4a. ther urea derivatives 4 (b-d)and thiourea derivatives 4 (e-k)were synthesized by adopting the above synthetic procedure.the compounds thus obtained were characterized by elemental analysis, 1, C MR, mass spectra and elemental analysis. 3-Ethyl-5-methyl-4-(2-chlorophenyl)-2-((2-(3-(4-chlorophenyl)ureido)ethoxy)methyl)-6-methyl-1,4-dihydro pyridine-3,5-dicarboxylate (4a): Yield0%; mp 1- o C;IR (KBr) (v max cm -1 ):162 (C=), 115 (C=),336 (); 1 -MR (DMS- d 6 ) δ ppm: 1. (t, 3, C 3, -), 2. (s, 3, C 3, -15), 3.1 (dd, 2, C 2, -), 3.30 (s, 3, C 3, -), 3.60 (t, 2, C 2, -), 4.0 (s, 2, C 2, -),4.23 (m, 2, C 2, -),4.40 (s, 1, C, -4), 5.0 (t, 1,, -),.-.0 (m,, Ar-),.20 (s, 1,, -1),.21 (s, 1, -24); C-MR (DMS-d 6 )δ(ppm): 15.2 (C-), 1. (C- 15), 3.2 (C-4), 3.0 (C-), 54.0 (C-), 60.2 (C-), 6. (C-), 6.0 (C-), 3.1 (C-5), 3. (C-3),1.3 (C-2 &C- 6 ), 6.1 (C-21), 6. (C-20),.4 (C-1),.0 (C-1), 0.4 (C-3 &C-5 ), 1.0 (C-1), 3. (C-4 ), 6.5 (C- 1 ) 2. (C-6), 4.3 (C-2), 4.6 (C-16), 15.1 (C-23), 166.4 (C-), 166.5(C-); LCMSmass m/z (%)562.3 (0%)[M+] +., 564.2 (65%), 40.5 (60%).Anal.cald.forC 2 2 2 3 6 :C 5.66; 5.20;.4;FoundC 5.60; 5.16;.41; 3-Ethyl-5-methyl-4-(2-chlorophenyl)-2-((2-(3-(3,4-dichlorophenyl)ureido)ethoxy)methyl)- 6-methyl-1,4- dihydropyridine-3,5-dicarboxylate (4b) Yield 4%; mp 1-200 o C;IR (KBr) (v max cm -1 ):16 (C=), 11 (C=),336 (); 1 -MR (DMS- d 6 ) δ ppm: 1.2 (t, 3, C 3, -), 2.15 (s, 3, C 3, -15), 3.23 (dd, 2, C 2, -), 3.35 (s, 3, C 3, -), 3.65 (t, 2, C 2, -), 4. (s, 2, C 2, -),4.2 (m, 2, C 2, -),4.45 (s, 1, C, -4), 5.5 (t, 1,, -),.2-.5 (m,, Ar-),.25 (s, 1,, -1),.26 (s, 1, -24); C-MR (DMS-d 6 )δ(ppm): 15.25 (C-), 1.5 (C-15), 3.25 (C-4), 3.05 (C-), 54.05 (C-), 60.25 (C-), 6.5 (C-), 6.05 (C-), 3.15 (C-5), 3.5 (C- 3),2.4 (C-5 ), 5.2 (C-6 ), 6.15 (C-21), 6.5 (C-20),.45 (C-1),.05 (C-1), 0. (C-3 ), 1.3 (C-2 ), 1.1 (C-1),. (C-4 ), 5. (C-1 ),2. (C-6), 4.4 (C-2), 4.65 (C-16), 15. (C-23), 166.5 (C-), 166.55(C-); LCMSmass m/z (%)56.4 (0%)[M+] +., 5.3 (66%), 40.2 (52%).Anal.cald.forC 2 2 3 3 6 :C 54.33; 4.3;.04;FoundC 54.2; 4.0;.02; 3-Ethyl-5-methyl-4-(2-chlorophenyl)-2-[(2-[(4-isocyanatoanilino)carbonyl]aminoethoxy)methyl]-6-methyl-1,4- dihydro-3,5-pyridinedicarboxylate(4c) Yield 3%; mp5- o C;IR (KBr) (v max cm -1 ):162 (C=), 4 (C=),335 (); 1 -MR (DMS- d 6 ) δ ppm: 1.26 (t, 3, C 3, -), 2. (s, 3, C 3, -15), 3. (dd, 2, C 2, -), 3.34 (s, 3, C 3, -), 3.64 (t, 2, C 2, -), 4. (s, 2, C 2, -),4.2 (m, 2, C 2, -),4.44 (s, 1, C, -4), 5.4 (t, 1,, -),.25-.64 (m,, Ar-),.24 (s, 1,, -1),.15 (s, 1, -24); C-MR (DMS-d 6 )δ(ppm): 15.24 (C-), 1.4 (C-15), 3.24 (C-4), 3.04 (C-), 54.04 (C-), 60.24 (C-), 6.4 (C-), 6.4 (C-), 3. (C-5), 3.4 (C- 3),0.2 (C-2 &C-6 ),6. (C-21), 6.4 (C-20),.44 (C-1),.04 (C-1),.2 (C- ), 6.2 (C-3 &C-5 ),.5 (C-4 ), 1.04 (C-1), 6.1 (C-1 ), 2.4 (C-6), 4.34 (C-2), 4.64 (C-16), 15.2 (C-23), 166.44 (C-), 166.54(C-); LCMSmass m/z (%)56.6 (0%)[M+] +., 51.5 (64%), 40.4 (2%).Anal.cald.forC 2 2 4 :C 5.; 5.;.5;FoundC 5.05; 5.0;.0; 201

C. aga Raju et al Der Pharmacia Lettre, 20, 5 (1):1-204 3-Ethyl-5-methyl-2-((2-(3-(3-chloro-4-fluorophenyl)ureido)ethoxy)methyl)-4-(2-chlorophenyl)- 6-methyl-1,4- dihydropyridine-3,5-dicarboxylate (4d) Yield %; mp 15-1 o C;IR (KBr) (v max cm -1 ):165 (C=), 1 (C=),336 (); 1 -MR (DMS- d 6 ) δ ppm: 1.25 (t, 3, C 3, -), 2. (s, 3, C 3, -15), 3.21 (dd, 2, C 2, -), 3.33 (s, 3, C 3, -), 3.63 (t, 2, C 2, -), 4. (s, 2, C 2, -),4.26 (m, 2, C 2, -),4.43 (s, 1, C, -4), 5.3 (t, 1,, -),.24-.5 (m,, Ar-),.23 (s, 1,, -1),.24 (s, 1, -24); LCMSmass m/z (%)50.2 (0%)[M+] +., 52.5 (65%), 40.5 (6%).Anal.cald.forC 2 2 2 F 3 6 :C 55.; 4.6;.24;FoundC 55.1; 4.;.15; 3-Ethyl-5-methyl-2-((2-(3-allylthioureido)ethoxy)methyl)-4-(2-chlorophenyl)- 6-methyl-1,4-dihydropyridine- 3,5-dicarboxylate (4e) Yield 5%; mp20-20 o C;IR (KBr) (v max cm -1 ): 63 (C=S), 163 (C=), 3321 (); 1 -MR (DMS- d 6 ) δ ppm: 1.24 (t, 3, C 3, -), 2. (s, 3, C 3, -15), 3.20 (dd, 2, C 2, -), 3.32 (s, 3, C 3, -), 3.62 (t, 2, C 2, -), 4.0 (s, 2, C 2, -), 4.25 (m, 2, C 2, -),4.42 (s, 1, C, -4), 4.-5.6 (m, 5, -C 2 - C=C 2 ), 5.2 (t, 1,, -),.00-.0 (m, 4, Ar-),. (s, 1,, -1),.23 (s, 1, -24); C-MR (DMS-d 6 )δ(ppm): 15. (C-), 1.2 (C-15), 3. (C-4), 3.02 (C-), 40.4 (C-1 ), 54.02 (C-), 60. (C-), 6.2 (C-), 6.02 (C-), 3. (C-5), 3.2 (C-3),.6 (C-3 ), 6. (C-21), 6.2 (C-20),.42 (C- 1),.02 (C-1), 1.02 (C-1), 4. (C-2 ), 2.2 (C-6), 4.32 (C-2), 4.62 (C-16), 166.42 (C-), 166.52(C- ), 15. (C-23); LCMSmass m/z (%)50.3 (0%)[M+] +., 5.5 (65%), 40.5 (5%). Anal.cald. forc 24 30 3 5 S: C56.4; 5.5;.2;FoundC 56.6; 5.0;.21; 3-Ethyl-5-methyl-4-(2-chlorophenyl)-2-((2-(3-phenylthioureido)ethoxy)methyl)-6-methyl-1,4-dihydropyridine -3,5-dicarboxylate (4f) : Yield 3%; mp 1-11 o C;IR (KBr) (v max cm -1 ):55 (C=S), 166 (C=), 326 (); 1 -MR (DMS- d 6 ) δ ppm: 1.23 (t, 3, C 3, -), 2. (s, 3, C 3, -15), 3.1 (dd, 2, C 2, -), 3.31 (s, 3, C 3, -), 3.61 (t, 2, C 2, -), 4.0 (s, 2, C 2, -),4.24 (m, 2, C 2, -),4.41 (s, 1, C, -4), 5.1 (t, 1,, -), 6.3-.62 (m,, Ar-),.21 (s, 1,, -1),. (s, 1, -24); C-MR (DMS-d 6 )δ(ppm): 15.2 (C-), 1. (C- 15), 3.2 (C-4), 3.1 (C-), 54.1 (C-), 60.2 (C-), 6. (C-), 6.1 (C-), 3.1 (C-5), 3. (C-3),6.2 (C-2 &C- 6 ),6.1 (C-21), 6. (C-20),.4 (C-1),.6 (C-4 ),.01 (C-1),.2 (C-3 &C-5 ), 1.01 (C-1),.3 (C-1 ), 2.1 (C-6), 4.31 (C-2), 4.61 (C-16), 166.41 (C-), 166.5(C-),.2 (C-23); LCMSmass m/z (%)544.2 (0%)[M+] +., 546.5 (33%), 40.2 (66%).Anal.cald.forC 2 30 3 5 S:C 5.61; 5.56;.2;FoundC 5.54; 5.51;.65; 3-Ethyl 5-methyl 4-(2-chlorophenyl)-2-((2-(3-(4-chlorophenyl)thioureido)ethoxy)methyl)- 6-methyl-1,4- dihydro pyridine-3,5-dicarboxylate (4g) Yield 0%; mp 14-16 o C;IR (KBr) (v max cm -1 ): 4 (C=S), 166 (C=), 324 (); 1 -MR (DMS- d 6 ) δ ppm: 1.1 (t, 3, C 3, -), 2.05 (s, 3, C 3, -15), 3. (dd, 2, C 2, -), 3.25 (s, 3, C 3, -), 3.55 (t, 2, C 2, -), 4.02 (s, 2, C 2, -),4.1 (m, 2, C 2, -),4.35 (s, 1, C, -4), 5.5 (t, 1,, -), 6.5-.5 (m,, Ar-),.15 (s, 1,, -1),.16 (s, 1, -24); C-MR (DMS-d 6 )δ(ppm): 15.15 (C-), 1.65 (C-15), 3.15 (C-4), 3.5 (C-), 53.5 (C-), 60.15 (C-), 6.5 (C-), 6.5 (C-), 3.05 (C-5), 3.65 (C- 3),6.05 (C-21), 6.5 (C-20),.35 (C-1),.5 (C-1), 0. (C-3 &C-5 ), 0. (C-1), 1.2 (C-2 &C-6 ), 2. (C-4 ), 5.2 (C-1 ), 2.65 (C-6), 4.25 (C-2), 4.55 (C-16), 166.35 (C-), 166.45(C-),.4 (C-23); LCMSmass m/z (%)5.2 (0%)[M+] +., 5. (65%), 40.5 (54%).Anal.cald.forC 2 2 2 3 5 S:C 56.06; 5.05;.26;FoundC 56.02; 5.01;.1; 3-Ethyl 5-methyl 4-(2-chlorophenyl)-2-((2-(3-(4-nitrophenyl)thioureido)ethoxy)methyl)- 6-methyl-1,4-dihydro pyridine-3,5-dicarboxylate (4h) Yield 5%; mp215-21 o C;IR (KBr) (v max cm -1 ): 46 (C=S), 166 (C=), 325 (); 1 -MR (DMS- d 6 ) δ ppm: 1.1 (t, 3, C 3, -), 2.06 (s, 3, C 3, -15), 3. (dd, 2, C 2, -), 3.26 (s, 3, C 3, -), 3.56 (t, 2, C 2, -), 4.03 (s, 2, C 2, -),4.1 (m, 2, C 2, -),4.36 (s, 1, C, -4), 5.6 (t, 1,, -),.1-. (m,, Ar-),.16 (s, 1,, -1),.1 (s, 1, -24); LCMSmass m/z (%)5. (0%)[M+] +., 51.5 (33%), 40.2 (4%).Anal.cald.forC 2 2 4 S:C 55.05; 4.6;.51;FoundC 55.01; 4.;.42; 3-Ethyl 5-methyl 4-(2-chlorophenyl)-2-((2-(3-(3-nitrophenyl)thioureido)ethoxy)methyl)- 6-methyl-1,4-dihydro pyridine-3,5-dicarboxylate (4i) Yield 0%; mp20-2 o C;IR (KBr) (v max cm -1 ): 4 (C=S), 1662 (C=), 32 (); 1 -MR (DMS-d 6 ) δ ppm: 1.1 (t, 3, C 3, -), 2.0 (s, 3, C 3, -15), 3.15 (dd, 2, C 2, -), 3.2 (s, 3, C 3, -), 3.5 (t, 2, 202

C. aga Raju et al Der Pharmacia Lettre, 20, 5 (1):1-204 C 2, -), 4.04 (s, 2, C 2, -),4.1 (m, 2, C 2, -),4.35 (s, 1, C, -4), 5.5 (t, 1,, -), 6.4-.5 (m,, Ar-),.15 (s, 1,, -1),.16 (s, 1, -24); LCMSmass m/z (%)5. (0%)[M+] +., 51.5 (33%), 40.3 (50%).Anal.cald.forC 2 2 4 S: C 55.05; 4.6;.51; FoundC 55.01; 4.;.42; 3-Ethyl 5-methyl 4-(2-chlorophenyl)-2-((2-(3-(2-nitrophenyl)thioureido)ethoxy)methyl)- 6-methyl-1,4-dihydro pyridine-3,5-dicarboxylate (4j) Yield 3%; mp2-2 o C;IR (KBr) (v max cm -1 ): 51 (C=S), 1663 (C=), 3266 (); 1 -MR (DMS- d 6 ) δ ppm: 1.20 (t, 3, C 3, -), 2.0 (s, 3, C 3, -15), 3.16 (dd, 2, C 2, -), 3.2 (s, 3, C 3, -), 3.5 (t, 2, C 2, -), 4.05 (s, 2, C 2, -),4.21 (m, 2, C 2, -),4.3 (s, 1, C, -4), 5. (t, 1,, -),.-.0 (m,, Ar-),.1 (s, 1,, -1),.1 (s, 1, -24); LCMSmass m/z (%)5. (0%)[M+] +., 51.5 (33%), 40.2 (52%).Anal.cald.forC 2 2 4 S: C 55.05; 4.6;.51;FoundC 55.01; 4.;.42; 3-Ethyl 5-methyl 4-(2-chlorophenyl)-2-((2-(3-(2,4-dichlorophenyl)thioureido)ethoxy)methyl)- 6-methyl-1,4- dihydropyridine-3,5-dicarboxylate (4k) Yield 5%; mp -15 o C;IR (KBr) (v max cm -1 ):45 (C=S), 165 (C=),325 (); 1 -MR (DMS- d 6 ) δ ppm: 1.21 (t, 3, C 3, -), 2. (s, 3, C 3, -15), 3.1 (dd, 2, C 2, -), 3.31 (s, 3, C 3, -), 3.61 (t, 2, C 2, -), 4.06 (s, 2, C 2, -),4. (m, 2, C 2, -),4.41 (s, 1, C, -4), 5.1 (t, 1,, -),.31-.6 (m,, Ar-),.21 (s, 1,, -1),.20 (s, 1, -24); LCMSmass m/z (%)6.4 (0%)[M+] +., 6.5 (33%), 40.6 (6%).Anal.cald.forC 2 2 3 3 5 S:C 52.1; 4.60; 6.6;FoundC 52.2; 4.54; 6.; Table 1 Antifungal activity of compounds 4a-j Compound 4a 4b 4c 4d 4e 4f 4g 4h 4i 4j Griseofulvin Zone of inhibition (in mm) Colletotrichumgloeosporioides Aspergillusniger 250 500 250 500 6 15 6 1 15 16 20 15 1 16 20-20 - Table 2 Antibacterial activity of compounds 4a-j Compound Zone of inhibition(in mm) S aureus B subtilis E coli K pneumoniae 250 500 250 500 250 500 250 500 4a 4b 4c 4d 4e 4f 4g 4h 4i 4j Penicillin 20 1 1 1 1 15 15 16 Antimicrobial activity Susceptibility of test organisms to the title compounds 4(a-k) was determined by employing the standard disc diffusion technique []. All the compounds 4(a-k) were tested for their antifungal activity against the growth of Colletotrichumgleosorioides and Aspergillusnigeralong with the standard fungicide Griseofulvin at concentrations of 250 and 500 µg/disc, according to the reported procedure [].(Table1). Title compounds 4(a-k)were also screened for their anti-bacterial activity against the growth of Staphylococcus aureus, Bacillus subtilis, Escherichia 203

C. aga Raju et al Der Pharmacia Lettre, 20, 5 (1):1-204 coli and Klebsiellapeumoniaealong with the standard Penicillin at concentrations of 250 and 500 µg/disc according to the reported method [].(Table2). The results revealed that the title compounds exhibited moderate anti-fungal and good anti-bacterial activity against the tested species. RESULTS AD DISCUSSI Synthesis of a series of urea/thiourea derivatives 4(a-k) was accomplished through a single-step process. Benzene sulfonic acid was removed from Amlodipine by treating with Et 3 in TF at 50 o C. Then Amlodipine was reacted with different isocyanates/isothiocyanates in the presence of Et 3 in TF at 40-50 o Cto form 4(a-k). The progress of the reaction was monitored by TLC analysis at different time intervals and the crude products obtained after removing the solvent were purified by column chromatography on silica gel using ethylacetate and hexane (2:3) as step grade mixtures as eluents. The structures of 4(a-k) were established by elemental analysis, IR, 1, C MR and mass spectral data (Scheme 1). The synthetic and analytical data of title compounds 4(a-k) are given in the experimental part. All the compounds4(a-k) exhibited absorption bands for C= and - in the regions 165-162 and 3260-3340 cm -1. In the 1 MR spectra (400 Mz) of 4(a-k), aromatic protons resonated as multipletsin the region 6.1-.5 ppm. The proton signals were observed in the region.0-.40 ppm as singlets. The C MR spectra for a few compounds were recorded and the data are given in the experimental part. The C= and C=S carbons gave signals in the regions 15.2-15.1and.2-15.ppmrespectively. The remaining carbon signals are observed in the expectedregions. The LC-MS of a few of the title compounds were recorded and the data are given in the experimental part. CCLUSI Amlodipine was treated with differentisocyanates/isothiocyanates to form urea/thiourea derivatives with high yields5-5%. Modification of Amlodipine as its urea/thiourea derivatives exhibited good antibacterial activity against two Gram positive and two Gram negative bacteria andmoderate antifungal activity against two different fungi. Acknowledgements The authors express their grateful thanks to UGC, ew Delhi, for giving financial assistance through BSR fellowship. REFERECES [1] D. V. M. Renaud Tissier, P. Sebastien, D. V. M. Brigitte Enriquez, J. Vet. Cardi.,2005,, 53. [2] R. A. enik, P. S. Snyder, L. M. Volk, J. Vet. Intern. Med.,14,,. [3] D. M. Considine, G. D. Considine, Van ostrand Reinhold Encyclopedia of Chemistry.Vanostrand Reinhold Company,ew York,14. [4] (a) F. M. Uckun, S. Pendergrass, D. Maher, D. Zhu, L. Tuel-Ahlgren, C. Mao, T. K. Venkatachalam, Bioorg. Med. Chem. Lett., 1,, 34. (b) R. Vig, C. Mao, T. K. Venkatachalam, L. Tuel-Ahlgren, E. A. Sudbeck, F. M. Uckun, Bioorg. Med. Chem.,1, 6, 1. [5] C. Sanmartin, M. Echeverria, B. Mendvil, L. Cordeu, E. Cubedo, J. Garcia-Fon-Cillas, M. Fontc, J. A. Palop, Bioorg. Med. Chem., 2005,, 2031. [6] G. allur, A. Jimeno, S. Dalrymple, T. Zhu, M.K. Jung, M. idalgo, J.T. Isaacs,S. Sukumar, E. amel, S.R. Khan, J. Med. Chem., 2006, 4, 235. [] S.. Manjula,. M. oolvi, K. V. Parihar, S. A. M. Reddy, V. Ramani, A. K. Gadad, G. Sing,.G. Kutty, C. M. Rao, Eur. J. Med. Chem., 200, 44, 3. [] Y.M. Zhang, T.B.Wei, L. Xian, L.M. Gao, Phosphorus, Sulphur Silicon Relat. Elem., 2004, 1, 200. [] W. Q. Zhou, B. L. Li, L. M. Zhu, J. G. Ding, Z. Yong, L. Lu, X.J. Yang, J. Mol. Struct., 2004, 60, 5. [] M. Eweis, S.S. Elkholy, M.Z. Elsabee, Int. J. Biol. Macromol.,2006, 3, 1. [] A. W. Bauer, W. M. Kirby, J. C, Sherris, M. Truck,Am. J. in. Pathol.,166, 45, 43. [] Y. B. Kiran, M. Kasthuraiah, C. aga Raju, D. GunaSekhar, S. V. S. MadhuBabu, C. Devendranath Reddy, Indian J. Chem., 2005, 44B, 211. [] Sanjeevkumar, Turk J Chem.,20, 35,. 204

2024 © healthdocbox.com Privacy Policy | Terms of Service | Feedback